GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLRB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Strong day for Cellectar Biosciences stock price on Monday rising 5.28% to $3.19
(Updated on Apr 22, 2024)

Sell candidate since Apr 09, 2024 Loss -14.48% PDF

The Cellectar Biosciences stock price gained 5.28% on the last trading day (Monday, 22nd Apr 2024), rising from $3.03 to $3.19. During the last trading day the stock fluctuated 8.90% from a day low at $2.97 to a day high of $3.23. The price has fallen in 8 of the last 10 days and is down by -16.27% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 59 thousand more shares were traded than the day before. In total, 866 thousand shares were bought and sold for approximately $2.76 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.03 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.28% during the next 3 months and, with a 90% probability hold a price between $2.93 and $4.03 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLRB Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 5.28%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cellectar Biosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.23 and $3.69. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cellectar Biosciences stock

Cellectar Biosciences finds support from accumulated volume at $3.04 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.264 between high and low, or 8.90%. For the last week, the stock has had daily average volatility of 7.13%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLRB) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Cellectar Biosciences to open at $3.13, and during the day (based on 14 day Average True Range), to move between $2.95 and $3.43, which gives a possible trading interval of +/-$0.243 (+/-7.61%) up or down from last closing price. If Cellectar Biosciences takes out the full calculated possible swing range there will be an estimated 15.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.04 (4.70%) than the resistance at $3.78 (18.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cellectar Biosciences stock A Buy?

Cellectar Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -1.856 Sell Candidate Upgraded

Predicted Opening Price for Cellectar Biosciences of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$3.13 ( 1.95%) $3.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLRB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.39 6.32 %
R2 3.29 3.16 %
R1 3.23 1.21 %
Current price: 3.19
Support S1 3.03 -5.10 %
S2 2.96 -7.06 %
S3 2.86 -10.22 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.98 24.76 %
R2 3.87 21.32 %
R1 3.78 18.50 %
Current price 3.19
Support S1 3.04 -4.70%
S2 3.03 -5.02%
S3 0 .

FAQ

What is the symbol for Cellectar Biosciences Stock and on which exchange is it traded?
The symbol for Cellectar Biosciences is CLRB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectar Biosciences Stock?
Cellectar Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Cellectar Biosciences Stock?
Cellectar Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectar Biosciences Stock.

What's the current price of Cellectar Biosciences Stock?
As of the end of day on the Apr 22, 2024, the price of an Cellectar Biosciences (CLRB) share was $3.19.

What is the 52-week high and low for Cellectar Biosciences Stock?
The 52-week high for Cellectar Biosciences Stock is $4.45 and the 52-week low is $1.33.

What is the market capitalization of Cellectar Biosciences Stock?
As of the Apr 22, 2024, the market capitalization of Cellectar Biosciences is 102.911M.

When is the next earnings date for Cellectar Biosciences?
The upcoming earnings date for Cellectar Biosciences is May 02, 2024.
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT